The importance of conservative measures in peripheral arterial disease: an update.
Paraskevas
Kosmas I
KI
Papas
Theofanis T
TT
Pavlidis
Polyvios
P
Bessias
Nikolaos
N
Andrikopoulos
Vassilios
V
D043925:Angiogenesis Inducing Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000503:physiopathology; D018450:Disease Progression; D050171:Dyslipidemias / Q000188:drug therapy / Q000503:physiopathology; D015444:Exercise / Q000502:physiology; D006801:Humans; D018919:Neovascularization, Physiologic / Q000187:drug effects; D016491:Peripheral Vascular Diseases / Q000503:physiopathology / Q000628:therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012907:Smoking / Q000503:physiopathology; D016540:Smoking Cessation
D043925:Angiogenesis Inducing Agents; D000959:Antihypertensive Agents; D010975:Platelet Aggregation Inhibitors